JPS6340538A - Ct image diagnostic method - Google Patents
Ct image diagnostic methodInfo
- Publication number
- JPS6340538A JPS6340538A JP61183304A JP18330486A JPS6340538A JP S6340538 A JPS6340538 A JP S6340538A JP 61183304 A JP61183304 A JP 61183304A JP 18330486 A JP18330486 A JP 18330486A JP S6340538 A JPS6340538 A JP S6340538A
- Authority
- JP
- Japan
- Prior art keywords
- injection
- cylinder means
- injected
- site
- diagnosis target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 238000003745 diagnosis Methods 0.000 claims description 35
- 239000007924 injection Substances 0.000 claims description 34
- 238000002347 injection Methods 0.000 claims description 34
- 239000002872 contrast media Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 13
- 239000002504 physiological saline solution Substances 0.000 claims description 13
- 230000005856 abnormality Effects 0.000 claims description 4
- 238000010586 diagram Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
Landscapes
- Analysing Materials By The Use Of Radiation (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Abstract] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
〔発明の目的〕
(産業上の利用分野)
本発明は、医用診断の分野で用いられるC7画像診断装
置における画像診断方法、特に、離れた位置にある注入
部位から診断対象部位に対して造影剤を注入しながら診
断対象部位の異常検出を読影するCT画像診断方法の改
良に関するものである。Detailed Description of the Invention [Objective of the Invention] (Industrial Application Field) The present invention relates to an image diagnosis method in a C7 image diagnosis apparatus used in the field of medical diagnosis, and in particular, to an image diagnosis method using a C7 image diagnosis apparatus used in the field of medical diagnosis. The present invention relates to an improvement in a CT image diagnosis method for interpreting detected abnormalities in a diagnosis target site while injecting a contrast medium into the target site.
(従来の技術)
C7画像診断装置を用いた診断では、診断目的に応じて
定まる所定量の造影剤を患者(被検体)の体内に注入し
ながら患者の異常検出を時間の経過に基づいて読影して
いる。(Prior art) In diagnosis using a C7 image diagnostic system, a predetermined amount of contrast medium determined according to the purpose of diagnosis is injected into the body of the patient (subject), and abnormalities in the patient are detected and interpreted based on the passage of time. are doing.
この場合、普通には注入部位として腕部等が選ばれ血管
を注入系路として患部(診断対象部位)に造影剤が送ら
れるが、診断対象部位が例えば心臓のように注入部位(
この例では腕部等)から離れた位置にある場合には、造
影剤の注入に際して、この注入部位から診断対象部位に
至る長い注入系路内にどうしても造影剤が残留すること
になる。In this case, the arm or the like is usually selected as the injection site, and the contrast agent is sent to the affected area (diagnosis target area) using the blood vessel as the injection route.
In this example, if the contrast agent is located far away from the patient's arm (in this example), when the contrast agent is injected, the contrast agent will inevitably remain in the long injection path from the injection site to the diagnosis target site.
(発明が解決しようとする問題点)
而して、この残留造影剤は、画面トの所謂アーチファク
トの原因となるため、読影の際の診断画像に害をもたら
すばかりではなく、時間とCT値とのコントラスト変化
にも悪影響を与える虞れがあり、しかも、折角体内に注
入された造影剤が有効に利用されないために、ダイナミ
ック効果を充分に発揮し得ないという欠点にもつなかっ
一ζ来る。そのためこの問題の解決が強く望まれている
。(Problem to be Solved by the Invention) This residual contrast agent causes so-called artifacts on the screen, which not only harms diagnostic images during interpretation, but also reduces the time and CT value. This may adversely affect changes in the contrast of the patient, and furthermore, the contrast agent injected into the body is not effectively utilized, leading to the disadvantage that the dynamic effect cannot be fully demonstrated. Therefore, a solution to this problem is strongly desired.
本発明は、この事情に鑑みて成されたもので、グイナミ
ソク・スキャンによる飛躍的な臨床診断を向hL得るC
7画像診断方法を提供することを目的とする。The present invention has been made in view of this situation, and is a method for achieving rapid clinical diagnosis using the Guinamisoku Scan.
7 image diagnosis method.
(問題点を解決するための手段)
この目的を達成するための本発明の構成は、離れた位置
にある注入部位から診断対象部位に対して造影剤を注入
しながら診断対象部位の異常検出を読影するC7画像診
断方法において、先ず、注入部位から診断対象部位に対
して所定量の造影剤を汀太し、その後、該注入部位から
診断対象部位までの注入系路内に該系路を充填し得るh
士の生理食塩水を注入するようになしたことである。(Means for Solving the Problems) The configuration of the present invention to achieve this object detects abnormalities in the diagnosis target site while injecting a contrast agent from a distant injection site to the diagnosis target site. In the C7 image diagnosis method for image interpretation, first, a predetermined amount of contrast agent is applied from the injection site to the diagnosis target site, and then the injection system path from the injection site to the diagnosis target site is filled. can be done
This was done by injecting physiological saline.
(作 用)
そして、この構成に基づく本発明の作用は、注入部位か
ら診断対象部位までの注入系路内を人体及び読影に何等
の悪影響も及ぼさない生理食塩水で充填しようとする点
に存する
(実施例)
以下、図示の一実施例に基づいて本発明を詳述する。第
1図において、】及び2は後述の構造をもつ第1及び第
2のシリンダ手段で、第1シリンダ手段1には診断目的
に適合する造影剤Mが充填され、第2シリンダ手段2に
は生理食塩水Wが充填されている。(Function) The function of the present invention based on this configuration is that the injection system path from the injection site to the diagnosis target site is filled with physiological saline that does not have any adverse effects on the human body or image interpretation. (Example) Hereinafter, the present invention will be described in detail based on an example shown in the drawings. In FIG. 1, ] and 2 are first and second cylinder means having the structure described later, the first cylinder means 1 is filled with a contrast medium M suitable for diagnostic purposes, and the second cylinder means 2 is It is filled with physiological saline W.
3は該2つのシリンダ手段1・2のそれぞれの吐出管1
a・2aと連接するバルブ手段で、両吐出管1a・2a
からの液体を切換えて後1本の注入管4に導き得る構造
となっている。そして、後述する両シリンダ手段1・2
の運転切換えの信号がコントローラ6からそれぞれのシ
リンダ手段1または2に対して出力された時に、それと
連動して切換えられるように予め構成される。4(、[
前記バルブ手段3の他方側に連接した注入管で、その先
端は、適宜の方法により例えば被検体Pの腕部Aに選定
した注入部位Gに挿入される〔第3図参照(イ)〕。5
は該注入管4の周囲に設けられた圧力ゲージで、注入管
4を通過する液体の時間当たり圧力(流速)を計測する
。6は前記2つのシリンダ手段1・2等を制御するため
のコントローラで、その内部には2つのレジスタ6a・
6bを始め適宜の駆動力源(図示せず)が備えられる。3 is a discharge pipe 1 of each of the two cylinder means 1 and 2;
With valve means connected to a and 2a, both discharge pipes 1a and 2a
The structure is such that the liquid can be switched and guided to one injection tube 4 afterward. Both cylinder means 1 and 2, which will be described later,
It is configured in advance to be switched in conjunction with the operation switching signal outputted from the controller 6 to the respective cylinder means 1 or 2. 4(, [
The injection tube is connected to the other side of the valve means 3, and its tip is inserted into an injection site G selected on, for example, the arm A of the subject P by an appropriate method [see FIG. 3 (A)]. 5
is a pressure gauge provided around the injection pipe 4, which measures the pressure per hour (flow rate) of the liquid passing through the injection pipe 4. Reference numeral 6 denotes a controller for controlling the two cylinder means 1 and 2, etc., and inside thereof there are two registers 6a and 6a.
6b and other appropriate driving force sources (not shown) are provided.
7はCT画像診断装胃のスキャナ・システムである。7 is a scanner system for CT image diagnosis.
第2図に示すのは、前記2つのシリンダ手段の内の一方
(第1シリンダ手段1)を代表例として挙げたシリンダ
手段の概略構造図で、内部に充填されている液体の種類
が異なる外は第2シリンダ手段2も同様の構造となって
いる。FIG. 2 is a schematic structural diagram of a cylinder means, taking one of the two cylinder means (first cylinder means 1) as a representative example, and shows different types of liquid filled inside. The second cylinder means 2 also has a similar structure.
図中、101は該シリンダ手段lの本体、102はその
内部に設けられたシリンダで、適宜の方法により造影剤
Mが充填されている。103はこのシリンダ102と係
合する中空状のビスI・ンで、その外端部近傍の中空部
には後述するネジ部材105と螺合するナツト部103
aが設置され、外側の一部には後述する可動スイッチ1
08と係接するピストンヘッド103bが形成される。In the figure, 101 is the main body of the cylinder means I, and 102 is a cylinder provided therein, which is filled with a contrast medium M by an appropriate method. Reference numeral 103 designates a hollow screw I/N that engages with this cylinder 102, and a nut portion 103 that engages with a screw member 105, which will be described later, is provided in the hollow portion near its outer end.
A is installed, and a movable switch 1, which will be described later, is installed on a part of the outside.
A piston head 103b that engages with 08 is formed.
104ば該ピストン103を図において左右方向に駆動
させるための可逆回転式モータ(例えば直流モータやシ
ンクロナスモータ)で、入力される駆動エネルギの値(
駆動力量)によってその回転速度が定まるように構成さ
れ、動力線106を介して前記コントローラ6の駆動力
源に接続される。104 is a reversible rotary motor (for example, a DC motor or a synchronous motor) for driving the piston 103 in the left-right direction in the figure, and the input drive energy value (
It is configured such that its rotational speed is determined by the amount of driving force), and is connected to the driving force source of the controller 6 via a power line 106.
そして、その回転軸にはネジ部材105が固定される。A screw member 105 is fixed to the rotating shaft.
107は該シリンダ手段1の蓋でその一部には図におい
て左右方向に長く設定されたガイド溝107aが形成さ
れる。108は該ガイド溝107aに案内されて左右方
向に移動し得るように構成された可動スイッチで、図示
実施例では手動によってその位置を設定し得るようにな
っている。これは、ピストン103の移動量を規制して
吐出管1aへ流れる造影剤Mの流量を決定するためのも
のである。そして、その移動量(即ち、流量)の設定情
報は信号線109を介して前記コントローラ6に導入さ
れるように構成される。108aは該可動スイッチの作
動片である。Reference numeral 107 denotes a lid of the cylinder means 1, and a guide groove 107a, which is elongated in the left-right direction in the figure, is formed in a part of the lid. Reference numeral 108 denotes a movable switch configured to be able to move in the left and right directions while being guided by the guide groove 107a, and in the illustrated embodiment, its position can be set manually. This is for regulating the amount of movement of the piston 103 and determining the flow rate of the contrast medium M flowing into the discharge pipe 1a. The setting information of the amount of movement (ie, flow rate) is configured to be introduced to the controller 6 via a signal line 109. 108a is an operating piece of the movable switch.
尚、これらの部材101〜109は、第2シリンダ手段
2の場合にはそれぞれ201〜209となり、それに従
ってコントローラ6例の部材記号もそれぞれPW2.S
W2に置き変わり、更に、シリンダ202内に充填され
ている液体も生理食塩水に変わる。These members 101 to 109 are 201 to 209, respectively, in the case of the second cylinder means 2, and accordingly, the member symbols of the six controllers are also respectively PW2. S
W2 is replaced, and the liquid filled in the cylinder 202 is also changed to physiological saline.
次に、この構成になる本実施例の作用を各ステップに分
けて説明する。Next, the operation of this embodiment having this configuration will be explained in each step.
(第1ステツプ〕
先ず、第1シリンダ手段1のシリンダ102内に造影剤
Mを、第2シリンダ手段2のシリンダ202内に生理食
塩水Wをそれぞれ充填する。その後、第1シリンダ手段
1においては、診断目的に応じた造影剤Mの注入量を決
定すべく可動スイッチ108の位置を手動設定し、第2
シリンダ手段2においては、注入部位Gから診断対象部
位である心臓H(第3図(イ)参照〕までの系路(普通
には血管> r、を満たし得る生理食塩水Wの量を決定
すべく別の可動スイッチ20Bの位置を手動設定する。(First step) First, the contrast medium M is filled into the cylinder 102 of the first cylinder means 1, and the physiological saline W is filled into the cylinder 202 of the second cylinder means 2. Thereafter, in the first cylinder means 1, , the position of the movable switch 108 is manually set to determine the injection amount of contrast medium M according to the diagnostic purpose, and the second
The cylinder means 2 determines the amount of physiological saline W that can fill the path (usually blood vessels > If possible, manually set the position of another movable switch 20B.
そして、2個の可動スイッチ108・208の設定位置
情報は、信号線109・209を介してそれぞれコント
ローラ6側に入力され、レジスタ6a・6bに記憶され
る。The set position information of the two movable switches 108 and 208 is input to the controller 6 side via signal lines 109 and 209, respectively, and stored in the registers 6a and 6b.
〔第2ステツプ〕
前記CTスキャナ・システム7は造影剤M及び生理食塩
水Wの注入速度を決定して、それを5etup信号A及
びBとしてコントローラ6側に入力する。[Second Step] The CT scanner system 7 determines the injection speeds of the contrast medium M and physiological saline W, and inputs them as 5etup signals A and B to the controller 6 side.
この信号はコントローラ6内のレジスタ6a・6bに記
憶される。This signal is stored in registers 6a and 6b within the controller 6.
〔第3ステツプ〕
次に、CTスキャナ・システム7から作動信号STが発
せられる。するとコントローラ6は、第1シリンダ手段
lのモータ104に対して、一方のレジスタ6aに記憶
された情報に基づく速度で回転ずべきことを指示する駆
動力信号PWIを供給する。[Third Step] Next, the CT scanner system 7 issues an activation signal ST. Then, the controller 6 supplies a driving force signal PWI instructing the motor 104 of the first cylinder means 1 to rotate at a speed based on the information stored in one register 6a.
〔第4ステツプ〕
この結果、モーター04がそれに応じて回転してピスト
ン103を左方へ押し込むから、シリンダ102内の造
影剤Mが吐出管1a・バルブ手段3・注入管4を介して
被検体P内に注入され始める。[Fourth step] As a result, the motor 04 rotates accordingly and pushes the piston 103 to the left, so that the contrast medium M in the cylinder 102 is delivered to the subject via the discharge pipe 1a, the valve means 3, and the injection pipe 4. It begins to be injected into P.
〔第5ステツプ〕
さて、モーター04の回転につれてピストン103が左
方に移動すると、そのヘッド103bが可動スイッチの
作動片108aと系接して、ピストン103の移動量が
設定量に達したことを報知する検出信号SWIを、信号
線109を介してコントローラ6に入力する。そのため
、コントローラ6は直ちに駆動力信号PWIの供給を停
止する。従って、この時点で被検体Pの体内には所定量
の造影剤Mが注入され、第3図(ロ)に示すように、造
影剤Mが系路I7・診断対象部位■1・それ以後の系路
内を満たすことになる。[Fifth Step] Now, when the piston 103 moves to the left as the motor 04 rotates, its head 103b comes into contact with the actuating piece 108a of the movable switch to notify that the amount of movement of the piston 103 has reached the set amount. A detection signal SWI is input to the controller 6 via the signal line 109. Therefore, the controller 6 immediately stops supplying the driving force signal PWI. Therefore, at this point, a predetermined amount of contrast medium M is injected into the body of the subject P, and as shown in FIG. This will fill the system.
そして、コントローラ6はこれら同時にCTスキャナ・
システム7に対して造影剤Mの注入完了の信号Ackl
を出力する。The controller 6 simultaneously scans the CT scanner.
Signal Ackl to system 7 indicating completion of injection of contrast medium M
Output.
〔第6ステツプ〕
引き続づいて、コントローラ6は第2シリンダ手段2の
モータ204に対して、他方のレジスタ6aに記4aさ
れた情報に基づく所定の駆動力信号PW2を供給する。[Sixth Step] Subsequently, the controller 6 supplies the motor 204 of the second cylinder means 2 with a predetermined driving force signal PW2 based on the information recorded in the other register 6a.
そのため、第2シリンダ手段2のピストン203が前述
のケースと同様に移動して他方の可動スイッチの作動片
208aに係接する。そのため、ピストン103の移動
量が設定量に達したことを報知する検出信号SW2が信
号tflA209を介してコントローラ6に入力される
ことになり、その結果、コントローラ6は直ちに駆動力
信号PW2の供給を停止すると共に、CTスキャナ・シ
ステム7に対して生理食塩水Wの注入完了信号Ack2
を出力する。Therefore, the piston 203 of the second cylinder means 2 moves in the same way as in the case described above and comes into contact with the actuating piece 208a of the other movable switch. Therefore, the detection signal SW2 notifying that the amount of movement of the piston 103 has reached the set amount is input to the controller 6 via the signal tflA209, and as a result, the controller 6 immediately stops supplying the driving force signal PW2. At the same time, a physiological saline W injection completion signal Ack2 is sent to the CT scanner system 7.
Output.
従って、第3図(ハ)に示すように、前述の診断対象部
位H及びそれ以後の系路内には必要量の造影剤Mを保持
したまま、注入部位Gから診断対象部位Hに至る系路り
内は生理食塩水Wで満たされる状態になる。Therefore, as shown in FIG. 3(C), the system leading from the injection site G to the diagnosis target site H while retaining the required amount of contrast medium M in the aforementioned diagnosis target site H and the subsequent system path. The inside of the road is filled with physiological saline W.
これは、従来方式によれば前述の注入部位側の系路に残
留すべき造影剤が、生理食塩水の後押し作用によって診
断対象部位側で有効に使用されることを意味するから、
第4図に示すように、診断対象部位I]における時間と
CT値の変動とを示すタイムカーブ曲線のコントラスト
をも良化さセ゛ることが出来る。This means that the contrast agent that would remain in the system on the injection site side according to the conventional method is effectively used at the diagnosis target site due to the boosting action of the physiological saline.
As shown in FIG. 4, it is also possible to improve the contrast of the time curve curve showing time and CT value fluctuations in the diagnosis target site I.
以上一実施例について述べたが、本発明ばこれに限定さ
れるものではなく、その要旨を逸脱しt【い範囲内で種
々に変形実施することが出来る。例えば、図示実施例で
はバルブ手段を用いてし)るが、これは、造影剤と生理
食塩水との注入切換えが可能であるならば適宜の手段を
もって代用し得る。Although one embodiment has been described above, the present invention is not limited to this, and can be modified in various ways within the scope of departing from the gist thereof. For example, in the illustrated embodiment, a valve means is used, but this may be replaced by any suitable means if it is possible to switch between injections of contrast medium and saline.
以上述べたimり本発明を用いる時は、前述の注入部位
側の系路に残留する造影剤がなくなるので、残留造影剤
に起因する画像のアーチフプクトが著しく低減されると
いう効果を生ずる。When the present invention described above is used, since there is no contrast agent remaining in the system on the side of the injection site, the effect is that image artifacts caused by the residual contrast agent are significantly reduced.
1、 11, 1
第1図は本発明の画像診断方法を適用したCT画像診断
装置に係わる一実施例の全体概略図、第2図ぽ本実施例
に使用する2つのシリンダ手段の内の一方を代表例とし
て挙げたシリンダ手段の概略構造図、第3図(イ)・(
D)・(ハ)はいずれも本発明の詳細な説明するための
説明図、第4図は本発明の効果の一つである時間とCT
値の変動とを示すタイムカーブ曲線のコントラストを示
す性能図である。
A・・・腕部、G・・・注入部位、
H・・・心PM(診断対象部位)、L・・・系路、M・
・・造影剤、P・・・被検体(患者)、W・・・生理食
塩水、■・・・第1シリンダ手段、2・・・第2シリン
ダ手段、3・・・バルブ手段、4・・・注入管、5・・
・圧力計、6・・・コントローラ、7・・・CTスキャ
ナ・システム、
102・・・シリンダ、103・・・ピストン。Fig. 1 is an overall schematic diagram of an embodiment of a CT image diagnosis apparatus to which the image diagnosis method of the present invention is applied, and Fig. 2 shows one of the two cylinder means used in this embodiment as a representative example. Schematic structural diagram of the cylinder means shown in Figure 3 (a) and (
D) and (C) are explanatory diagrams for explaining the present invention in detail, and Fig. 4 shows time and CT, which is one of the effects of the present invention.
FIG. 3 is a performance diagram showing the contrast of time curve curves showing value fluctuations. A...Arm, G...Injection site, H...Cardiac PM (diagnosis target area), L...System tract, M...
... Contrast medium, P... Subject (patient), W... Physiological saline, ■... First cylinder means, 2... Second cylinder means, 3... Valve means, 4...・・Injection tube, 5・・
- Pressure gauge, 6... Controller, 7... CT scanner system, 102... Cylinder, 103... Piston.
Claims (3)
して造影剤を注入しながら診断対象部位の異常検出を読
影するCT画像診断方法において、先ず前記注入部位か
ら診断対象部位に対して所定量の造影剤を注入し、その
後、該注入部位から診断対象部位までの注入系路内に、
該系路を充填し得る量の生理食塩水を注入する如くなし
たことを特徴とするCT画像診断方法。(1) In a CT image diagnosis method in which a contrast agent is injected into a diagnosis target site from a distant injection site and interpreted to detect an abnormality in the diagnosis target site, first, a contrast agent is injected into the diagnosis target site from the injection site at a remote location. A fixed amount of contrast medium is injected, and then the injection system from the injection site to the diagnosis target area is injected.
1. A CT image diagnosis method, characterized in that physiological saline is injected in an amount sufficient to fill the system.
の注入口をもつ2個のシリンダ手段の順次操作によって
行なわれるものである特許請求の範囲第1項に記載のC
T画像診断方法。(2) C according to claim 1, wherein the injection of the contrast material and the injection of the physiological saline are performed by sequentially operating two cylinder means having a common injection port.
T image diagnosis method.
入口に設けたバルブ手段の切換えを伴うものである特許
請求の範囲第2項記載のCT画像診断方法。(3) The CT image diagnosis method according to claim 2, wherein the sequential operation of the two cylinder means is accompanied by switching of a valve means provided at the common injection port.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61183304A JPS6340538A (en) | 1986-08-06 | 1986-08-06 | Ct image diagnostic method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61183304A JPS6340538A (en) | 1986-08-06 | 1986-08-06 | Ct image diagnostic method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6340538A true JPS6340538A (en) | 1988-02-20 |
Family
ID=16133335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61183304A Pending JPS6340538A (en) | 1986-08-06 | 1986-08-06 | Ct image diagnostic method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6340538A (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006125588A (en) * | 2004-11-01 | 2006-05-18 | Ishikawajima Harima Heavy Ind Co Ltd | Supercharger and sealing device |
JP2006141497A (en) * | 2004-11-17 | 2006-06-08 | Medrad Inc | Lesion plotting method and lesion plotting system |
JP2006141498A (en) * | 2004-11-17 | 2006-06-08 | Medrad Inc | Method of injecting contrast agent and lesion plotting system |
JP2008544134A (en) * | 2005-06-16 | 2008-12-04 | ボーグワーナー・インコーポレーテッド | Disc member for turbocharger |
US7672710B2 (en) | 1994-09-21 | 2010-03-02 | Medrad, Inc. | Data communication and control for medical imaging systems |
US8568092B2 (en) | 2007-08-16 | 2013-10-29 | Ihi Corporation | Turbocharger |
US9008759B2 (en) | 2007-07-17 | 2015-04-14 | Bayer Medical Care Inc. | Devices and systems for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery |
US9238099B2 (en) | 2004-11-24 | 2016-01-19 | Bayer Healthcare Llc | System and apparatus for modeling pressures generated during an injection procedure |
US9302044B2 (en) | 2006-12-29 | 2016-04-05 | Bayer Healthcare Llc | Patient-based parameter generation systems for medical injection procedures |
US9616166B2 (en) | 2004-11-16 | 2017-04-11 | Bayer Healthcare Llc | Systems and methods of determining injection protocols for diagnostic imaging procedures |
US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US9959389B2 (en) | 2010-06-24 | 2018-05-01 | Bayer Healthcare Llc | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
US10898638B2 (en) | 2016-03-03 | 2021-01-26 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
US11478581B2 (en) | 2017-08-31 | 2022-10-25 | Bayer Healthcare Llc | Fluid injector system volume compensation system and method |
US11598664B2 (en) | 2017-08-31 | 2023-03-07 | Bayer Healthcare Llc | Injector pressure calibration system and method |
US11779702B2 (en) | 2017-08-31 | 2023-10-10 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
US11786652B2 (en) | 2017-08-31 | 2023-10-17 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
US11826553B2 (en) | 2017-08-31 | 2023-11-28 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
-
1986
- 1986-08-06 JP JP61183304A patent/JPS6340538A/en active Pending
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7937134B2 (en) | 1994-09-21 | 2011-05-03 | Medrad, Inc. | Systems for controlling injection and/or imaging procedures |
US8160679B2 (en) | 1994-09-21 | 2012-04-17 | Medrad, Inc. | Methods of coordinating an imaging procedure and an injection procedure |
US8055328B2 (en) | 1994-09-21 | 2011-11-08 | Medrad, Inc. | Interface unit for use with injectors and imaging systems and related devices |
US7672710B2 (en) | 1994-09-21 | 2010-03-02 | Medrad, Inc. | Data communication and control for medical imaging systems |
JP2006125588A (en) * | 2004-11-01 | 2006-05-18 | Ishikawajima Harima Heavy Ind Co Ltd | Supercharger and sealing device |
US9616166B2 (en) | 2004-11-16 | 2017-04-11 | Bayer Healthcare Llc | Systems and methods of determining injection protocols for diagnostic imaging procedures |
JP2006141497A (en) * | 2004-11-17 | 2006-06-08 | Medrad Inc | Lesion plotting method and lesion plotting system |
JP2006141498A (en) * | 2004-11-17 | 2006-06-08 | Medrad Inc | Method of injecting contrast agent and lesion plotting system |
US10166326B2 (en) | 2004-11-24 | 2019-01-01 | Bayer Healthcare Llc | Devices, systems and methods for determining parameters of one or more phases of an injection procedure |
US9950107B2 (en) | 2004-11-24 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for managing workflow for injection procedures |
US9238099B2 (en) | 2004-11-24 | 2016-01-19 | Bayer Healthcare Llc | System and apparatus for modeling pressures generated during an injection procedure |
JP2008544134A (en) * | 2005-06-16 | 2008-12-04 | ボーグワーナー・インコーポレーテッド | Disc member for turbocharger |
US9302044B2 (en) | 2006-12-29 | 2016-04-05 | Bayer Healthcare Llc | Patient-based parameter generation systems for medical injection procedures |
US10463782B2 (en) | 2006-12-29 | 2019-11-05 | Bayer Healthcare Llc | Patient-based parameter generation systems for medical injection procedures |
US9008759B2 (en) | 2007-07-17 | 2015-04-14 | Bayer Medical Care Inc. | Devices and systems for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery |
US8568092B2 (en) | 2007-08-16 | 2013-10-29 | Ihi Corporation | Turbocharger |
US9959389B2 (en) | 2010-06-24 | 2018-05-01 | Bayer Healthcare Llc | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
US11191501B2 (en) | 2012-05-14 | 2021-12-07 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US10898638B2 (en) | 2016-03-03 | 2021-01-26 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
US11672902B2 (en) | 2016-03-03 | 2023-06-13 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
US11478581B2 (en) | 2017-08-31 | 2022-10-25 | Bayer Healthcare Llc | Fluid injector system volume compensation system and method |
US11598664B2 (en) | 2017-08-31 | 2023-03-07 | Bayer Healthcare Llc | Injector pressure calibration system and method |
US11779702B2 (en) | 2017-08-31 | 2023-10-10 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
US11786652B2 (en) | 2017-08-31 | 2023-10-17 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
US11826553B2 (en) | 2017-08-31 | 2023-11-28 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6340538A (en) | Ct image diagnostic method | |
US7379533B2 (en) | Collision resolution in x-ray imaging systems | |
JP4293689B2 (en) | Contrast medium injection device | |
US20070015979A1 (en) | Method and device for generating an image using optical coherence tomography | |
US6834994B2 (en) | X-ray imaging apparatus for subtraction angiography | |
JPH0584296A (en) | Injection apparatus for medical use | |
WO2010101184A1 (en) | Chemical injection device and x-ray ct system | |
US5159622A (en) | X-ray fluoroscopic imaging apparatus with extended imaging set up range | |
US9295775B2 (en) | Device for injecting contrast media | |
WO2023016119A1 (en) | Interventional surgical robot driving device with catheter and guide wire diameter identification function | |
CN215874930U (en) | Intervene operation robot drive arrangement with stroke detects function | |
JPH08280664A (en) | Diagnostic ct apparatus for medical use | |
JP5063593B2 (en) | Chemical injection device | |
WO2000041819A1 (en) | Dispenser | |
JP5265520B2 (en) | Chemical injection device and method for controlling the chemical injection device | |
JPS63318932A (en) | Ultrasonic diagnostic apparatus | |
JPH06233752A (en) | Digital x-ray radiographing system | |
JPH06169888A (en) | Electronic endoscope system | |
JPH11137542A (en) | Bed controller for medical diagnostic equipment | |
JP3099900B2 (en) | Ultrasound diagnostic equipment | |
JP2948925B2 (en) | Endoscope device | |
JPH10191A (en) | Rotary stereographic equipment | |
JPH08131432A (en) | X-ray radiographing device | |
JP3356827B2 (en) | Ultrasound diagnostic equipment | |
JPH04266746A (en) | Ultrasonic diagnostic device |